Vanguard Global Advisers »

Nautilus Biotechnology shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $64k 17k 3.88

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Vanguard Capital Management
Hartland & Co
Comprehensive Financial Management
Amazon
Millennium Management
Clarius
_Sentinel Trust Company, LBA______________
Acadian Asset Management
Tikvah Management
Geode Capital Management

View all funds holding Nautilus Biotechnology